I&C Technology아이앤씨
052860 · KOSDAQ · ₩052860 · 아이앤씨
₩6,340▼ ₩240 (3.65%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩9B | ₩9B | ₩4.9B | ₩8.2B | ₩14B | ₩9.4B | ₩3.2B | ₩9.3B |
| Cost of sales | ₩5.3B | ₩5.1B | ₩4B | ₩3.3B | ₩7.9B | ₩6B | ₩5.5B | ₩6.4B |
| Gross profit | ₩3.6B | ₩3.9B | ₩888M | ₩4.9B | ₩6.5B | ₩3.4B | −₩2.2B | ₩2.8B |
| Operating income | ₩349M | ₩1B | −₩2.3B | ₩2.3B | ₩3.5B | ₩563M | −₩6.4B | −₩588M |
| Net income | −₩480M | ₩1B | ₩2B | −₩1.2B | ₩3B | ₩495M | −₩11B | ₩1.7B |
| Net income to shareholders | ₩527M | ₩1.1B | −₩1.7B | ₩2.4B | ₩3.4B | ₩479M | −₩6.8B | −₩707M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩54B | ₩55B | ₩53B | ₩54B | ₩57B | ₩53B | ₩51B | ₩57B |
| Current assets | ₩26B | ₩28B | ₩25B | ₩27B | ₩30B | ₩26B | ₩23B | ₩27B |
| Cash and equivalents | ₩5.3B | ₩1.5B | ₩10B | ₩1.9B | ₩11B | ₩1.4B | ₩4.7B | ₩1.8B |
| Total liabilities | ₩17B | ₩19B | ₩17B | ₩17B | ₩22B | ₩22B | ₩21B | ₩20B |
| Current liabilities | ₩15B | ₩17B | ₩16B | ₩15B | ₩21B | ₩21B | ₩19B | ₩19B |
| Borrowings | ₩6.9B | ₩12B | ₩12B | ₩12B | ₩15B | ₩15B | ₩15B | ₩15B |
| Total equity | ₩37B | ₩37B | ₩36B | ₩37B | ₩35B | ₩31B | ₩30B | ₩37B |
| Shareholders' equity | ₩37B | ₩36B | ₩35B | ₩36B | ₩34B | ₩30B | ₩30B | ₩36B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩347M | −₩720M | ₩9.2B | −₩7.2B | ₩9.6B | −₩3.2B | ₩4.4B | ₩2.5B |
| Capital spending | ₩137M | ₩66M | ₩79M | ₩60M | ₩15M | ₩5.4M | ₩15M | ₩83M |
| Free cash flow | −₩484M | −₩785M | ₩9.2B | −₩7.2B | ₩9.6B | −₩3.2B | ₩4.4B | ₩2.4B |
| Dividends paid | ₩0 | ₩0 | ₩0 | ₩0 | ₩0 | ₩0 | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: I&C Technology / 아이앤씨 / 052860 / KRX:052860
Source: KRX statistical information